Stock KYTHERA BIOPHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Kythera Biopharmaceuticals Inc

Equities

US5015701056

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Kythera Biopharmaceuticals Inc
2015 Allergan : forecasts second-half revenue above $8 billion RE

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Kythera Biopharmaceuticals Inc
  5. Analyst Reco.